BioSpace News Archive

Business

joimax® Announces Executive Appointments Among Record-Breaking Sales for 2022

joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has appointed Mr. Maximilian Ries and Mr. Anthony Troncale to new executive positions, effective January 1.

January 5, 2023
·
2 min read
Genetown

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 05, 2023

Viridian Therapeutics, Inc. announced that a majority of the independent directors serving on the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to an employee to purchase up to 35,000 shares of the Company’s common stock on January 3, 2023.

January 5, 2023
·
2 min read
Biotech Bay

CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics

CytomX Therapeutics, Inc. and Moderna, Inc. announced a collaboration and licensing agreement to create investigational mRNA-based conditionally activated therapies utilizing Moderna’s mRNA technologies and CytomX’s Probody® therapeutic platform.

January 5, 2023
·
10 min read
Business

Cyclacel Pharmaceuticals Reviews 2022 Achievements and Announces Key Business Objectives for 2023

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today provided a business update reviewing 2022 achievements and outlining the Company’s key business objectives for 2023.

January 5, 2023
·
7 min read
Deals

Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines

Ensoma, a genomic medicines company developing one-time in vivo treatments that precisely engineer any cell of the hematopoietic system, announced the completion of an $85 million financing.

January 5, 2023
·
6 min read
Biotech Bay

Mammoth Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference

Mammoth Biosciences, Inc. today announced its participation in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

January 5, 2023
·
1 min read
Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment

ViewRay, Inc. (NASDAQ: VRAY) announced today that Chindex Medical Limited (Chindex), through its subsidiary, has ordered 10 MRIdian® MR-Guided Therapy Systems.

January 5, 2023
·
6 min read
Pharm Country

Panavance Therapeutics to Present at the Virtual Investor 2023 Companies to Watch Event

Panavance Therapeutics Inc. today announced that Greg Bosch, Chairman and CEO of Panavance Therapeutics will present at the Virtual Investor 2023 Companies to Watch Event on Wednesday, January 18, 2023.

January 5, 2023
·
2 min read
Business

Montoux Announces Multi-Year Global Strategic Collaboration Agreement with AWS

To help life and health insurers accelerate their strategic modernization and digital transformation initiatives, Montoux Inc. (Montoux), a leading actuarial automation technology provider, today announced a strategic collaboration agreement (SCA) with Amazon Web Services, Inc. (AWS).

January 5, 2023
·
3 min read
Pharm Country

Integral Molecular Reveals Mechanism Underlying Exquisite Specificity of Claudin 6 Therapeutic Antibody Being Developed for Solid Tumors

Integral Molecular, the industry leader in antibody discovery for membrane proteins, has published the targeting mechanism enabling best-in-class specificity of its Claudin 6 antibody CTIM-76 being developed for cancer therapy with Context Therapeutics.

January 5, 2023
·
2 min read